Generic Drugs Market to Reach $835.7 Billion, Globally, by 2032 at 8.1% CAGR: Allied Market Research
20 juil. 2023 11h36 HE
|
Allied Market Research
Portland, OR, July 20, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Generic Drugs Market By Therapeutic Application (Cardiovascular, Infectious Diseases, Cancer,...
Viral Vector Production Market to reach $6.1 billion, Globally, by 2032 at 18.8% CAGR: Allied Market Research
13 juil. 2023 09h31 HE
|
Allied Market Research
Portland, OR, July 13, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Viral Vector Production Market by viral vector type (Adenoviral Vectors, Lentiviral Vectors,...
Veterinary Reference Laboratory Market to surpass USD 12 billion by 2032, Says Graphical Research Powered by GMI
12 juin 2023 21h00 HE
|
Graphical Research
Selbyville, Delaware, June 12, 2023 (GLOBE NEWSWIRE) -- Veterinary Reference Laboratory Market size will cross USD 12 billion by 2032. Increasing public-private investments in animal healthcare...
Global Sepsis Treatment Market likely to Cross USD 1.5 billion by 2031 along with a Moderate CAGR from 2021 to 2031: TMR study
09 juin 2023 06h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, June 09, 2023 (GLOBE NEWSWIRE) -- The global market for sepsis treatment was estimated to have reached a market valuation of around US$ 600 million in 2020. The...
Lyophilized Injectable Market Primed to Surpass USD 5 Billion by 2031, According to Transparency Market Research
05 juin 2023 06h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, June 05, 2023 (GLOBE NEWSWIRE) -- The global lyophilized injectable market is projected to exceed value of US$ 5 Bn by 2031. It is expected to expand at a CAGR...
AstriVax Awarded €2.5 Million Grant to Advance Innovative Vaccine Platform
30 mai 2023 00h00 HE
|
AstriVax
The government grant is awarded by Flanders Innovation & Entrepreneurship (VLAIO).The grant will be used to accelerate the company’s vaccine platform. The non-dilutive financing builds upon the...
Monoclonal Antibodies Market Sales are Anticipated to reach US$ 588.0 Billion by 2032, Increasing at 11.8% CAGR: Market.us Report
26 mai 2023 01h50 HE
|
Market.Us
New York, May 26, 2023 (GLOBE NEWSWIRE) -- The Monoclonal Antibodies Market size was valued at USD 198.2 Bn in 2022. The total market revenue is expected to grow at a CAGR of 11.8%, reaching...
Valo Therapeutics Announces First Patient Dosed with PeptiCRAd-1 - Innovative Immuno-oncology
23 mai 2023 03h00 HE
|
Valo Therapeutics LTD
HELSINKI, Finland, May 23, 2023 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapies for cancer, announces that the first patient has been treated in...
Icosavax Announces $67.8 Million Registered Direct Offering of Common Stock
22 mai 2023 17h53 HE
|
Icosavax, Inc.
SEATTLE, May 22, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
Icosavax Announces Positive Topline Interim Phase 1 Results for Bivalent VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults
22 mai 2023 17h37 HE
|
Icosavax, Inc.
– IVX-A12 induced robust immune responses at Day 28 to both RSV and hMPV in older adults – – IVX-A12 was generally well tolerated with no vaccine-related SAEs – – First demonstration of hMPV...